NDC 42023-164 – Vasostrict
Vasopressin, Unspecified 20 [USP'U]/mL · Injection · Intravenous
Product NDC42023-164
Product details
- Brand name
- Vasostrict
- Generic name
- Vasopressin
- Labeler
- Par Health USA, LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- NDA · NDA204485
- Marketed since
- November 12, 2014
- Listing expires
- December 31, 2027
Active ingredients
- Vasopressin, Unspecified 20 [USP'U]/mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 42023-164-10 | 10 VIAL in 1 CARTON (42023-164-10) / 1 mL in 1 VIAL (42023-164-01) | Aug 17, 2020 |
| 42023-164-25 | 25 VIAL in 1 CARTON (42023-164-25) / 1 mL in 1 VIAL (42023-164-01) | Nov 12, 2014 |
| 42023-164-83 | 25 VIAL in 1 CARTON (42023-164-83) / 1 mL in 1 VIAL | Dec 5, 2022 |
Recalls mentioning this NDC
- D-0232-2024 Jan 24, 2024 · Class II
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Other Vasostrict products
- 71872-7014 Vasopressin, Unspecified 20 [USP'U]/mL · Injection · Medical Purchasin Solutions, LLC
- 71872-7264 Vasopressin, Unspecified 20 [USP'U]/mL · Injection · Medical Purchasing Solutions, LLC
- 42023-190 Vasopressin, Unspecified 20 [USP'U]/mL · Injection · Par Health USA, LLC
- 42023-219 Vasopressin, Unspecified .4 [USP'U]/mL · Injection · Par Health USA, LLC
- 42023-237 Vasopressin, Unspecified .2 [USP'U]/mL · Injection · Par Health USA, LLC